Regenexx Alliant Webinar

We’re holding four sessions. Select the date & time that is the most convenient for you.

Why Join Us?

• Orthopedic diseases cost $980 billion annually and typically make up 20% of health plan spending. Regenexx can lower the cost of orthopedic surgery by up to 70% and dramatically impact total spending.
• This is the right thing for your clients. This solution can help your prospects and clients change the trajectory of their healthcare spend in a top 5 spending category.
• If you do not bring this solution as an option, your competitors will. Regenexx has worked with brokers across the country to add coverage on their own self-funded plan and/or to proactively bring this opportunity to their clients and prospects.

Employers Want This Solution

Regenexx has over 6MM covered lives. We started our program specifically, for self-funded employers in 2015.

• We have over 250 self-funded employers in our Corporate program and over 40 added coverage on 1/1/21.
• Regenexx has won the EHIR traction award twice in Cohort 3 and Cohort 4 by matching with some of the largest employers in America.
• Independent TPA’s and large TPA’s like Meritain have taken a proactive approach to bringing Regenexx to their clients.